InvestorsObserver
×
News Home

Can Black Diamond Therapeutics Inc (BDTX) Stock Rise to the Top of Healthcare Sector Monday?

Monday, October 16, 2023 11:29 AM | InvestorsObserver Analysts

Mentioned in this article

Can Black Diamond Therapeutics Inc (BDTX) Stock Rise to the Top of Healthcare Sector Monday?

Black Diamond Therapeutics Inc (BDTX) is near the top in its sector according to InvestorsObserver. BDTX gets an overall rating of 59. That means it scores higher than 59% of stocks. Black Diamond Therapeutics Inc gets a 90 rank in the Healthcare sector. Healthcare is number 6 out of 11 sectors.

Overall Score - 59
BDTX has an Overall Score of 59. Find out what this means to you and get the rest of the rankings on BDTX!

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. *Investors Observer* makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts. This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in the healthcare sector with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With Black Diamond Therapeutics Inc Stock Today?

Black Diamond Therapeutics Inc (BDTX) stock is trading at $2.35 as of 11:27 AM on Monday, Oct 16, a gain of $0.06, or 2.62% from the previous closing price of $2.29. The stock has traded between $2.30 and $2.43 so far today. Volume today is low. So far 203,079 shares have traded compared to average volume of 511,597 shares. Click Here to get the full Stock Report for Black Diamond Therapeutics Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App